Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
September 25, 2018
Reata Announces Positive Phase 2 Data for Bardoxolone Methyl in IgA Nephropathy and Type 1 Diabetic Chronic Kidney Disease
IRVING, Texas, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (RETA), a clinical-stage biopharmaceutical company, today announced positive, final results from the IgA nephropathy ...
September 25, 2018
Aptose to Present at Upcoming Investor Conferences in October 2018
SAN DIEGO, Calif. and TORONTO, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics ...
September 25, 2018
Arrowhead Pharmaceuticals to Present at Upcoming October 2018 Conferences
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (ARWR) today announced that it is scheduled to present at the following upcoming events: The 14th Annual Meeting of the ...
September 25, 2018
DURECT to Present at the Cantor Fitzgerald Global Healthcare Conference
CUPERTINO, Calif., Sept. 25, 2018 /PRNewswire/ -- DURECT Corporation (DRRX) announced today that James E. Brown, President and CEO, will be presenting at the Cantor Fitzgerald ...
September 25, 2018
Checkpoint Therapeutics Announces Presentation of Updated Data from Phase 1/2 Trial of EGFR Inhibitor CK-101
NEW YORK, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization ...
September 25, 2018
Eiger BioPharmaceuticals to Participate in Investor Conferences
PALO ALTO, Calif., Sept. 25, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for rare and ultra-rare ...
September 25, 2018
UroGen Pharma to Present at the Ladenburg Thalmann 2018 Healthcare Conference
RA’ANANA, Israel & NEW YORK--(BUSINESS WIRE)--UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with ...
September 25, 2018
Krystal Biotech to Present at Upcoming Cantor Fitzgerald and Ladenburg Thalmann Conferences
PITTSBURGH, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech Inc., (“Krystal”) (KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients ...
September 25, 2018
Zogenix to Present at LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology
EMERYVILLE, Calif., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) ...
September 25, 2018
Paratek Pharmaceuticals Presenting New Omadacycline Data at IDWeek 2018
BOSTON, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK) announced today that new data from its omadacycline clinical and microbiology programs will be ...
September 25, 2018
Catalyst Biosciences to Present at Two Upcoming Healthcare Investor Conferences
SOUTH SAN FRANCISCO, Calif., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology ...
September 25, 2018
Lipocine to Present at the Ladenburg Thalmann 2018 Healthcare Conference
SALT LAKE CITY, Sept. 25, 2018 /PRNewswire/ -- Lipocine Inc. (LPCN), a specialty pharmaceutical company, announced today that Dr. Mahesh Patel, Chairman, President and CEO, will ...
September 25, 2018
BioDelivery Sciences to Present at the Cantor Fitzgerald Global Healthcare Conference and the Ladenburg Thalmann 2018 Healthcare Conference
RALEIGH, N.C., Sept. 25, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (BDSI), a rapidly growing commercial stage specialty pharmaceutical company dedicated to patients living ...
September 25, 2018
Vaccinex, Inc. to Present at the Ladenburg Thalmann 2018 Healthcare Conference
ROCHESTER, N.Y., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (VCNX), a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat ...
September 25, 2018
Theravance Biopharma to Present at the 2018 Cantor Global Healthcare Conference
DUBLIN, Sept. 25, 2018 /PRNewswire/ -- Theravance Biopharma, Inc. (TBPH) announced today that members of management will present a corporate overview at the 2018 Cantor Global ...
September 25, 2018
Opiant Pharmaceuticals Announces Pricing of Public Offering of Common Stock
SANTA MONICA, Calif., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and drug abuse, ...
September 25, 2018
Molecular Templates, Inc. Announces Closing of Public Offering of Common Stock and the Full Exercise of the Underwriters’ Option to Purchase Additional Shares
AUSTIN, Texas, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (MTEM) (“Molecular”), a clinical-stage oncology company focused on the discovery and development of proprietary engineered ...
September 25, 2018
Y-mAbs Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
NEW YORK, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (YMAB) a late-stage clinical biopharmaceutical company focused on the development ...
September 25, 2018
Kuros Biosciences Appoints Strategic Advisory Board
SCHLIEREN (ZURICH), Switzerland, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Kuros Biosciences (SIX:KURN) today announced the formation of its Strategic Advisory Board (SAB). The newly-formed SAB ...
September 24, 2018
Gemphire Therapeutics Announces Workforce Reduction
LIVONIA, Mich., Sept. 24, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, ...
Page 37 of 138